{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T21:40:59Z","timestamp":1725658859152},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T00:00:00Z","timestamp":1221609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00403-008-0887-5","type":"journal-article","created":{"date-parts":[[2008,9,16]],"date-time":"2008-09-16T08:38:15Z","timestamp":1221554295000},"page":"545-550","source":"Crossref","is-referenced-by-count":7,"title":["The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis"],"prefix":"10.1007","volume":"300","author":[{"given":"Tsutomu","family":"Ohtsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,17]]},"reference":[{"key":"887_CR1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0049-0172(96)80035-7","volume":"25","author":"P Barrera","year":"1996","unstructured":"Barrera P, Boerbooms AM, van de Putte LB, van der Meer JW (1996) Effects of antirheumatic agents on cytokines. Semin Arthritis Rheum 25:234\u2013253. doi: 10.1016\/S0049-0172(96)80035-7","journal-title":"Semin Arthritis Rheum"},{"key":"887_CR2","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1093\/clinchem\/39.11.2235","volume":"39","author":"MH Beresini","year":"1993","unstructured":"Beresini MH, Davalian D, Alexander S et al (1993) Evaluation of EMIT cyclosporine assay for use with whole blood. Clin Chem 39:2235\u20132241","journal-title":"Clin Chem"},{"key":"887_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/07853890500401234","volume":"38","author":"E Bonora","year":"2006","unstructured":"Bonora E (2006) The metabolic syndrome and cardiovascular disease. Ann Med 38:64\u201380. doi: 10.1080\/07853890500401234","journal-title":"Ann Med"},{"key":"887_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/hrt.47.3.239","volume":"47","author":"FC Beer de","year":"1982","unstructured":"de Beer FC, Hind CR, Fox KM et al (1982) Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 47:239\u2013243. doi: 10.1136\/hrt.47.3.239","journal-title":"Br Heart J"},{"key":"887_CR5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","volume":"157","author":"T Fredriksson","year":"1978","unstructured":"Fredriksson T, Pettersson U (1978) Severe psoriasis\u2014oral therapy with a new retinoid. Dermatologica 157:238\u2013244","journal-title":"Dermatologica"},{"key":"887_CR6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB et al (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735\u20131741. doi: 10.1001\/jama.296.14.1735","journal-title":"JAMA"},{"key":"887_CR7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1365-2133.2008.08564.x","volume":"158","author":"P Gisondi","year":"2008","unstructured":"Gisondi P, Giglio MD, Cotena C, Girolomoni G (2008) Combining etenercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 158:1345\u20131349. doi: 10.1111\/j.1365-2133.2008.08564.x","journal-title":"Br J Dermatol"},{"key":"887_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","volume":"157","author":"P Gisondi","year":"2007","unstructured":"Gisondi P, Tessari G, Conti A et al (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 157:68\u201373. doi: 10.1111\/j.1365-2133.2007.07986.x","journal-title":"Br J Dermatol"},{"issue":"Suppl 67","key":"887_CR9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.0366-077X.2004.05949.x","volume":"150","author":"CE Griffiths","year":"2004","unstructured":"Griffiths CE, Dubertret L, Ellis CN et al (2004) Cyclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol 150(Suppl 67):11\u201323. doi: 10.1111\/j.0366-077X.2004.05949.x","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"887_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07343.x","volume":"155","author":"CE Griffiths","year":"2006","unstructured":"Griffiths CE, Katsambas A, Dijkmans BA et al (2006) Update on the use of cyclosporin in immune-mediated dermatoses. Br J Dermatol 155(Suppl 2):1\u201316. doi: 10.1111\/j.1365-2133.2006.07343.x","journal-title":"Br J Dermatol"},{"key":"887_CR11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","volume":"32","author":"T Henseler","year":"1995","unstructured":"Henseler T, Christopher E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982\u2013986. doi: 10.1016\/0190-9622(95)91336-X","journal-title":"J Am Acad Dermatol"},{"key":"887_CR12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2133.2002.04836.x","volume":"147","author":"VM Heydendael","year":"2002","unstructured":"Heydendael VM, Spuls PI, Ten Berge IJ et al (2002) Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels. Br J Dermatol 147:122\u2013129. doi: 10.1046\/j.1365-2133.2002.04836.x","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"887_CR13","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","volume":"53","author":"G Krueger","year":"2005","unstructured":"Krueger G, Ellis CN (2005) Psoriasis\u2014recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 53(Suppl):S94\u2013S100. doi: 10.1016\/j.jaad.2005.04.035","journal-title":"J Am Acad Dermatol"},{"key":"887_CR14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0190-9622(98)70325-1","volume":"39","author":"M Lebwohl","year":"1998","unstructured":"Lebwohl M, Ellis C, Gottlieb A et al (1998) Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol 39:464\u2013475. doi: 10.1016\/S0190-9622(98)70325-1","journal-title":"J Am Acad Dermatol"},{"key":"887_CR15","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","volume":"91","author":"P Libby","year":"1995","unstructured":"Libby P (1995) Molecular bases of the acute coronary syndromes. Circulation 91:2844\u201328450","journal-title":"Circulation"},{"key":"887_CR16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","volume":"331","author":"G Liuzzo","year":"1994","unstructured":"Liuzzo G, Biasucci LM, Gallimore JR et al (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417\u2013424. doi: 10.1056\/NEJM199408183310701","journal-title":"N Engl J Med"},{"key":"887_CR17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0954-6111(98)90002-6","volume":"92","author":"JE Losa Garc\u00eda","year":"1998","unstructured":"Losa Garc\u00eda JE, Mateos Rodr\u00edguez F et al (1998) Effect of cyclosporin A on inflammatory cytokine production by human alveolar macrophages. Respir Med 92:722\u2013728. doi: 10.1016\/S0954-6111(98)90002-6","journal-title":"Respir Med"},{"key":"887_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","volume":"156","author":"RJ Ludwig","year":"2007","unstructured":"Ludwig RJ, Herzog C, Rostock A et al (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156:271\u2013276. doi: 10.1111\/j.1365-2133.2006.07562.x","journal-title":"Br J Dermatol"},{"key":"887_CR19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2006.07503.x","volume":"155","author":"M Malerba","year":"2006","unstructured":"Malerba M, Gisondi P, Radaeli A et al (2006) Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 155:1165\u20131169. doi: 10.1111\/j.1365-2133.2006.07503.x","journal-title":"Br J Dermatol"},{"key":"887_CR20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/B:EJEP.0000020447.59150.f9","volume":"19","author":"L Mallbris","year":"2004","unstructured":"Mallbris L, Akre O, Granath F et al (2004) Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 19:225\u2013230. doi: 10.1023\/B:EJEP.0000020447.59150.f9","journal-title":"Eur J Epidemiol"},{"key":"887_CR21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11926-006-0065-8","volume":"8","author":"L Mallbris","year":"2006","unstructured":"Mallbris L, Ritchlin CT, Stahle M (2006) Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 8:355\u2013363. doi: 10.1007\/s11926-006-0065-8","journal-title":"Curr Rheumatol Rep"},{"key":"887_CR22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM199704033361409","volume":"335","author":"A Maseri","year":"1997","unstructured":"Maseri A (1997) Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med 335:1014\u20131016. doi: 10.1056\/NEJM199704033361409","journal-title":"N Engl J Med"},{"key":"887_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MED.0b013e3282be90a8","volume":"14","author":"MR Meyers","year":"2007","unstructured":"Meyers MR, Gokce N (2007) Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 14:365\u2013369","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"887_CR24","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.intimp.2007.05.021","volume":"7","author":"M Mitamura","year":"2007","unstructured":"Mitamura M, Nakano N, Yonekawa T et al (2007) T cells are involved in the development of arthritis induced by anti-type II collagen antibody. Int Immunopharmacol 7:1360\u20131368. doi: 10.1016\/j.intimp.2007.05.021","journal-title":"Int Immunopharmacol"},{"key":"887_CR25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0190-9622(90)70354-K","volume":"23","author":"G Mockli","year":"1990","unstructured":"Mockli G, Kabra PM, Kurtz TW (1990) Laboratory monitoring of cyclosporine levels: guidelines for the dermatologist. J Am Acad Dermatol 23:1275\u20131279","journal-title":"J Am Acad Dermatol"},{"key":"887_CR26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","volume":"55","author":"AL Neimann","year":"2006","unstructured":"Neimann AL, Shin DB, Wang X et al (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829\u2013835. doi: 10.1016\/j.jaad.2006.08.040","journal-title":"J Am Acad Dermatol"},{"key":"887_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.1988.tb01773.x","volume":"118","author":"A Peserico","year":"1988","unstructured":"Peserico A, Zanetti G, Padovan S et al (1988) Relationship between body weight and blood pressure and some metabolic parameters in psoriatic patients. Br J Dermatol 118:191\u2013194. doi: 10.1111\/j.1365-2133.1988.tb01773.x","journal-title":"Br J Dermatol"},{"key":"887_CR28","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.103.13.1813","volume":"103","author":"PM Ridker","year":"2001","unstructured":"Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813\u20131818","journal-title":"Circulation"},{"key":"887_CR29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","volume":"150","author":"P Rocha-Pereira","year":"2004","unstructured":"Rocha-Pereira P, Santos-Silva A, Rebelo RI et al (2004) The inflammatory response in mild and in severe psoriasis. Br J Dermatol 150:917\u2013928. doi: 10.1111\/j.1365-2133.2004.05984.x","journal-title":"Br J Dermatol"},{"key":"887_CR30","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","volume":"101","author":"B Schieffer","year":"2000","unstructured":"Schieffer B, Schieffer E, Hilfiker-Kleiner D et al (2000) Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 101:1372\u20131378","journal-title":"Circulation"},{"key":"887_CR31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMc051541","volume":"353","author":"MP Schon","year":"2005","unstructured":"Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 353:848\u2013850. doi: 10.1056\/NEJMc051541","journal-title":"N Engl J Med"},{"key":"887_CR32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0190-9622(94)70208-X","volume":"31","author":"D Seckin","year":"1994","unstructured":"Seckin D, Tokgozoglu L, Akkaya S (1994) Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis? J Am Acad Dermatol 31:445\u2013449","journal-title":"J Am Acad Dermatol"},{"key":"887_CR33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2133.1994.tb03411.x","volume":"130","author":"M Seishima","year":"1994","unstructured":"Seishima M, Seishima M, Mori S, Noma A (1994) Serum lipid and apolipoprotein in patients with psoriasis. Br J Dermatol 130:738\u2013742. doi: 10.1111\/j.1365-2133.1994.tb03411.x","journal-title":"Br J Dermatol"},{"key":"887_CR34","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/ajhp\/55.15.1598","volume":"55","author":"N Shibata","year":"1998","unstructured":"Shibata N, Hayakawa T, Hoshino N et al (1998) Effect of obesity on cyclosporine trough concentrations in psoriasis patients. Am J Health Syst Pharm 55:1598\u20131602","journal-title":"Am J Health Syst Pharm"},{"key":"887_CR35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/clinchem\/45.3.371","volume":"45","author":"W Steimer","year":"1999","unstructured":"Steimer W (1999) Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem 45:371\u2013381","journal-title":"Clin Chem"},{"key":"887_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2006.07.011","volume":"190","author":"M Wakkee","year":"2007","unstructured":"Wakkee M, Thio HB, Presn EP et al (2007) Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Athrosclerosis 190:1\u20139. doi: 10.1016\/j.atherosclerosis.2006.07.011","journal-title":"Athrosclerosis"},{"key":"887_CR37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","volume":"42","author":"MM Ward","year":"1999","unstructured":"Ward MM (1999) Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 42:338\u2013346. doi:10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","journal-title":"Arthritis Rheum"},{"key":"887_CR38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0002-9149(99)00653-0","volume":"85","author":"J Zhu","year":"2000","unstructured":"Zhu J, Quyyumi AA, Norman JE et al (2000) Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 85:140\u2013146. doi: 10.1016\/S0002-9149(99)00653-0","journal-title":"Am J Cardiol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0887-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-008-0887-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0887-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T08:46:42Z","timestamp":1588927602000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-008-0887-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,17]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s00403-008-0887-5","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,17]]}}}